Enzymicals AG announces management transition of the CEO to the Supervisory Board
BRAIN Biotech AG and Enzymicals AG are pleased to announce that Dr. Erik de Vries has joined BRAIN Biotech as Senior Business Development Director Enzymes as of June 1st, 2024. De Vries will continue in his current position as CEO of Enzymicals AG on a part-time basis during a transition phase until the end of the year.